Scientific Programme
Thursday, 28 April 2016
9.00 - Opening Session – Laranja Pontes, Leonor David
9.30 – 11.00 - Symposium I - Tumour Immunology
Chairs: José Dinis, Jocelyne Demengeot
9.30 -10.00 - Invited speaker: Bruno Silva Santos
Gamma-delta T lymphocytes in the tumour environment: from oncoimmunology to adoptive cell immunotherapy
10.00 – 10.30 - Invited speaker: Jolanda de Vries
Harnessing adaptive immune responses in hereditary cancer
10.30 – 10.45 – Célia Gomes - Natural Killer cell-based adoptive immunotherapy eradicates and promotes the differentiation of chemoresistant stem-like cells
10.45 – 11.00 – Karine Serre - Tumour-associated neutrophils inhibit pro-tumour IL17-producing gamma-delta T cells
11.00 – 11.30 – Coffee break
11.30 – 13.00 - Symposium II – Immunomodulation of Cancer
Chairs: Bruno Silva Santos, Júlio Oliveira
11.30 -12.00 - Invited speaker: Frederick Arce Vargas
Targeting immune regulation in the tumour site
12.00 – 12.30 - Invited speaker: Jeffrey Weber
Efficacy and Biomarker Analyses of the Use of Checkpoint Inhibition in Melanoma
12.30 – 12.45 – Ana Catarina Pinho - Functional capacity of tumor lysate-pulsed monocyte-derived dendritic cells inducing in vitro immune responses
12.45 – 13.00 – Paulo Rodrigues-Santos - PD-1 downregulation on Tregs during Tyrosine Kinase Inhibitor therapy in Chronic Myeloid Leukemia
13.00 – 14.00 – Lunch
14.00 – 16.00 – Poster Parallel Sessions
Chairs: Ana Teresa Maia, Ana Preto, Fátima Carneiro, Gabriela Sousa, Isabel Fonseca, Margarida Damasceno, Maria João Cardoso, Maria José Bento, Nuno Lunet, Nuno Sousa, Raquel Seruca, Rui Henrique e Sílvia Socorro
16.00 – 16.30 – Coffee break
16.30 – 18.00 - Symposium III – Radiation Biology and Radiotherapy
Chairs: Luísa Carvalho, Pedro Almeida
16.30 -17.00 - Invited speaker: Rolf Lewensohn
Molecular tumour response to accelerated ions and role of cellular modifying factors
17.00 – 17.30 - Invited speaker: Marie Dutreix
Focus on the combination of DNA repair inhibitors with radiotherapy
17.30 – 17.45 – Paula Boaventura - TERT promoter mutations in thyroid carcinoma from childhood irradiated tinea capitis patients
17.45 – 18.00 – Ana T. Pinto - Macrophages modulate colorectal cancer cell response to radiation
18.00 – 19.00 - ASPIC General Assembly
20.00 - Congress Dinner
Friday, 29 April 2016
9.30 – 11.00 - Symposium IV – Signaling Pathways – The Androgen Receptor model
Chairs: Carmen Jerónimo, Nuno Sousa
9.30 -10.00 - Invited speaker: Wytske van Weerden
The continued role of AR in castration-resistant prostate cancer
10.00 – 10.30 - Invited speaker:Tiffany Traina
The role of the AR in advanced breast cancer
10.30 – 10.45 – Cristina Amaral - Estrogen-dependent breast cancer: the involvement of androgen receptor in exemestane-acquired resistance
10.45 – 11.00 – Inês Graça - Androgen Receptor mediates castration-resistant prostate cancer cells response to the DNMT inhibitor Hydralazine
11.00 – 11.30 – Coffee break
11.30 – 13.00 - Symposium V – Cell and Tumour Biology
Chairs: Luís Costa, Fátima Baltazar
11.30 -12.00 - Invited speaker - Gunther Boysen
Molecular features of SPOP mutant/ CHD1 deleted prostate cancer
12.00 -12.30 – Invited speaker - Joan Seoane
Tackling intratumour heterogeneity in brain tumors
12.30 – 12.45 – Joana Vieira de Castro - Autofluorescence as a new biomarker to identify Glioblastoma Stem Cells
12.45 – 13.00 – Ana Sofia Ribeiro - P-cadherin, a therapy predictive biomarker for Dasatinib in basal-like triple negative breast cancer
13.00 – 14.00 - Lunch
14.00 – 16.30 – Plenary Lectures and Awards
Chairs: Manuel Sobrinho Simões, Nuno Miranda, Jorge Soares, Carlos Camps
14.00 - 14h45 - ASPIC Lecture – Alberto Cambrosio
Mapping the development of Portuguese clinical research in oncology
14h45 - 15h30 - ASEICA Lecture – Luis Paz Ares
Lung cancer precision treatment
15h30 - 16h15 - EACR Lecture - Richard Marais
RAS and RAF signalling in melanoma: from basic biology to clinical responses
16h15 - 16h30 - Awards and closing